X- linked recessive
|
phenotype |
|
Finding
|
172
|
1
|
0.100 |
None |
|
0 |
|
|
|
Dysfunctional alternative complement pathway
|
phenotype |
|
Finding
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of metabolism/homeostasis
|
phenotype |
|
Finding
|
171
|
5
|
0.100 |
None |
|
0 |
|
|
|
Properdin Deficiency, Type III
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases
|
Disease or Syndrome
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Properdin Deficiency, Type II
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases
|
Disease or Syndrome
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.310 |
None |
1.000 |
1 |
|
2019 |
2019 |
Complement deficiency disease
|
group |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
42
|
|
0.300 |
strong |
1.000 |
1 |
|
1980 |
1980 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Hallucinations, Auditory
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Sign or Symptom
|
14
|
4
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Iron deficiency
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
179
|
13
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Papillary Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
223
|
3
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |
Dysphoric mood
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
22
|
6
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Memory impairment
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
763
|
48
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Rapidly progressive glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
19
|
1
|
0.010 |
None |
1.000 |
1 |
|
1984 |
1984 |
Anhedonia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
93
|
7
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Thymic Dysplasia
|
disease |
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Violence
|
phenotype |
|
Mental or Behavioral Dysfunction
|
70
|
6
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Vascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
688
|
40
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Autism Spectrum Disorders
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1071
|
331
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Alcohol withdrawal syndrome
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Disease or Syndrome
|
67
|
6
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
opioid use
|
disease |
|
Mental or Behavioral Dysfunction
|
39
|
5
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
McCune-Albright Syndrome
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
45
|
10
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Fibrous Dysplasia
|
disease |
|
Congenital Abnormality
|
53
|
5
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
early pregnancy
|
phenotype |
|
Disease or Syndrome
|
273
|
8
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Anxiety symptoms
|
phenotype |
|
Sign or Symptom
|
110
|
10
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |